180 Life Sciences Ownership 2024 | Who Owns 180 Life Sciences Now?

Overview RevenueFinancials Chart

Institutional Ownership

15799.84%

Insider Ownership

2.78%

Retail Ownership

-15702.62%

Institutional Holders

27.00

180 Life Sciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	5.86%	0.00%	114,736	92,000	404.64%	207,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.22%	-	23,928	23,928	100.00%	43,070,000	Mar 31, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	1.20%	0.00%	23,521	23,521	100.00%	42,338,000	Mar 31, 2023
VANGUARD GROUP INC	0.81%	-	15,795	-38,415	-70.86%	28,431,000	Mar 31, 2023
BLACKROCK INC.	0.76%	-	14,968	-3,364	-18.35%	26,942,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.72%	0.00%	14,071	14,071	100.00%	25,328,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	10,602	2	0.02%	19,083,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.12%	0.00%	2,299	-3,037	-56.92%	4,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.06%	-	1,180	1,180	100.00%	2,124,000	Mar 31, 2023
MORGAN STANLEY	0.04%	-	738	-114	-13.38%	1,328,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.01%	-	180	180	100.00%	324,000	Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.	0.01%	0.00%	100	100	100.00%	180,000	Mar 31, 2023
SANDY SPRING BANK	0.00%	-	50	-	-	90,000	Mar 31, 2023
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.	0.00%	-	25	-	-	45,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	1	10.00%	20,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	3	3	100.00%	5,000	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2023
MARATHON TRADING INVESTMENT MANAGEMENT LLC	-	-	-	-15,200	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-5,871	-100.00%	-	Mar 31, 2023
CUTLER GROUP LLC / CA	-	-	-	-365	-100.00%	-	Mar 31, 2023

180 Life Sciences's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 5.86% of the company's total share outstanding, currently valued at $207.00K. The top 10 institutional shareholders own together 11.32% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	5.86%	0.00%	114,736	92,000	404.64%	207,000	Mar 31, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	1.20%	0.00%	23,521	23,521	100.00%	42,338,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.12%	0.00%	2,299	-3,037	-56.92%	4,000	Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.	0.01%	0.00%	100	100	100.00%	180,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.72%	0.00%	14,071	14,071	100.00%	25,328,000	Mar 31, 2023
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.	0.00%	-	25	-	-	45,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.22%	-	23,928	23,928	100.00%	43,070,000	Mar 31, 2023
SANDY SPRING BANK	0.00%	-	50	-	-	90,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	10,602	2	0.02%	19,083,000	Mar 31, 2023
BLACKROCK INC.	0.76%	-	14,968	-3,364	-18.35%	26,942,000	Mar 31, 2023
VANGUARD GROUP INC	0.81%	-	15,795	-38,415	-70.86%	28,431,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.06%	-	1,180	1,180	100.00%	2,124,000	Mar 31, 2023
MORGAN STANLEY	0.04%	-	738	-114	-13.38%	1,328,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.01%	-	180	180	100.00%	324,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	3	3	100.00%	5,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	1	10.00%	20,000	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2023
MARATHON TRADING INVESTMENT MANAGEMENT LLC	-	-	-	-15,200	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-5,871	-100.00%	-	Mar 31, 2023
CUTLER GROUP LLC / CA	-	-	-	-365	-100.00%	-	Mar 31, 2023

The largest 180 Life Sciences shareholder by % of total assets is RENAISSANCE TECHNOLOGIES LLC. The company owns 114.74K shares of 180 Life Sciences (ATNF), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	5.86%	0.00%	114,736	92,000	404.64%	207,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.22%	-	23,928	23,928	100.00%	43,070,000	Mar 31, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	1.20%	0.00%	23,521	23,521	100.00%	42,338,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.72%	0.00%	14,071	14,071	100.00%	25,328,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.06%	-	1,180	1,180	100.00%	2,124,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.01%	-	180	180	100.00%	324,000	Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.	0.01%	0.00%	100	100	100.00%	180,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	3	3	100.00%	5,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	10,602	2	0.02%	19,083,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	1	10.00%	20,000	Mar 31, 2023
SANDY SPRING BANK	0.00%	-	50	-	-	90,000	Mar 31, 2023
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.	0.00%	-	25	-	-	45,000	Mar 31, 2023
FMR LLC	-	-	-	-2	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-2	-100.00%	-	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-84	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.04%	-	738	-114	-13.38%	1,328,000	Mar 31, 2023
CUTLER GROUP LLC / CA	-	-	-	-365	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.12%	0.00%	2,299	-3,037	-56.92%	4,000	Mar 31, 2023
BLACKROCK INC.	0.76%	-	14,968	-3,364	-18.35%	26,942,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-5,871	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, 180 Life Sciences's largest institutional buyer is RENAISSANCE TECHNOLOGIES LLC. The company purchased 92.00K stocks of ATNF, valued at $207.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SIMPLEX TRADING, LLC	-	-	-	-83,900	-100.00%	-	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	0.81%	-	15,795	-38,415	-70.86%	28,431,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-34,546	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-20,829	-100.00%	-	Mar 31, 2023
MARATHON TRADING INVESTMENT MANAGEMENT LLC	-	-	-	-15,200	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-5,871	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	0.76%	-	14,968	-3,364	-18.35%	26,942,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.12%	0.00%	2,299	-3,037	-56.92%	4,000	Mar 31, 2023
CUTLER GROUP LLC / CA	-	-	-	-365	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.04%	-	738	-114	-13.38%	1,328,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-84	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-2	-100.00%	-	Mar 31, 2023
FMR LLC	-	-	-	-2	-100.00%	-	Mar 31, 2023
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.	0.00%	-	25	-	-	45,000	Mar 31, 2023
SANDY SPRING BANK	0.00%	-	50	-	-	90,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	11	1	10.00%	20,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.54%	-	10,602	2	0.02%	19,083,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	3	3	100.00%	5,000	Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.	0.01%	0.00%	100	100	100.00%	180,000	Mar 31, 2023

As of Mar 31 2023, 180 Life Sciences's biggest institutional seller is SIMPLEX TRADING, LLC. The company sold -83.90K shares of ATNF, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CITADEL ADVISORS LLC	1.22%	-	23,928	23,928	100.00%	43,070,000	Mar 31, 2023
CUBIST SYSTEMATIC STRATEGIES, LLC	1.20%	0.00%	23,521	23,521	100.00%	42,338,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.72%	0.00%	14,071	14,071	100.00%	25,328,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.06%	-	1,180	1,180	100.00%	2,124,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.01%	-	180	180	100.00%	324,000	Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.	0.01%	0.00%	100	100	100.00%	180,000	Mar 31, 2023
FIRST MANHATTAN CO. LLC.	0.00%	-	3	3	100.00%	5,000	Mar 31, 2023

180 Life Sciences's largest new institutional shareholder by number of shares is CITADEL ADVISORS LLC, purchased 23.93K shares, valued at $43.07M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SIMPLEX TRADING, LLC	-	-	-	-83,900	-100.00%	-	Mar 31, 2023
SIMPLEX TRADING, LLC	-	-	-	-58,200	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-34,546	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-20,829	-100.00%	-	Mar 31, 2023
MARATHON TRADING INVESTMENT MANAGEMENT LLC	-	-	-	-15,200	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-5,871	-100.00%	-	Mar 31, 2023
CUTLER GROUP LLC / CA	-	-	-	-365	-100.00%	-	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-84	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-2	-100.00%	-	Mar 31, 2023
FMR LLC	-	-	-	-2	-100.00%	-	Mar 31, 2023

180 Life Sciences's largest sold out institutional shareholder by shares sold is SIMPLEX TRADING, LLC, sold -83.90K shares, valued at -, as of undefined.

180 Life Sciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
SPECIAL OPPORTUNITIES FUND, INC.	0.06%	24,050	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.01%	348,908	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	1,058,757	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	198,918	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	16,667	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	95,704	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	7,214	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	30,049	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	833	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	6,277	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	65,747	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	314	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	3,368	-	-	Mar 31, 2024

180 Life Sciences's largest mutual fund holder by % of total assets is "SPECIAL OPPORTUNITIES FUND, INC.", owning 24.05K shares, compromising 0.06% of its total assets.

180 Life Sciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	27	-15.63%
30 Jun, 22	32	-17.95%
31 Mar, 22	39	-18.75%
31 Dec, 21	48	17.07%
30 Sep, 21	41	-10.87%
30 Jun, 21	46	39.39%
31 Mar, 21	33	266.67%
31 Dec, 20	9	-

As of 30 Sep 22, 27 institutions are holding 180 Life Sciences's shares, representing a decrease of -15.63% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	6,190,377	151.69%
30 Jun, 22	2,459,525	-10.95%
31 Mar, 22	2,761,954	-13.96%
31 Dec, 21	3,209,964	23.05%
30 Sep, 21	2,608,658	17.04%
30 Jun, 21	2,228,924	37.70%
31 Mar, 21	1,618,666	15.36%
31 Dec, 20	1,403,164	-

180 Life Sciences (ATNF) has 6.19M shares outstanding as of 30 Sep 22, up 151.69% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	15799.84%	0.03%
30 Jun, 22	7208.46%	0.01%
31 Mar, 22	8109.08%	0.01%
31 Dec, 21	9457.76%	0.02%
30 Sep, 21	7740.82%	0.02%
30 Jun, 21	7084.95%	0.02%
31 Mar, 21	5789.22%	0.01%
31 Dec, 20	6354.91%	-

As of 30 Sep 22, 180 Life Sciences is held by 15799.84% institutional shareholders, representing a 0.03% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	4	-60.00%
30 Jun, 22	10	-23.08%
31 Mar, 22	13	-50.00%
31 Dec, 21	26	52.94%
30 Sep, 21	17	-26.09%
30 Jun, 21	23	-8.00%
31 Mar, 21	25	177.78%
31 Dec, 20	9	-

4 institutional shareholders have increased their position in ATNF stock as of 30 Sep 22 compared to 10 in the previous quarter (a -60.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	8	60.00%
30 Jun, 22	5	-54.55%
31 Mar, 22	11	22.22%
31 Dec, 21	9	28.57%
30 Sep, 21	7	-
30 Jun, 21	7	600.00%
31 Mar, 21	1	-
31 Dec, 20	-	-

8 institutional shareholders have reduced their position in ATNF stock as of 30 Sep 22 compared to 5 in the previous quarter (a 60.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	27	-15.63%	6,190,377	151.69%	15799.84%	0.03%	4	-60.00%	8	60.00%
30 Jun, 22	32	-17.95%	2,459,525	-10.95%	7208.46%	0.01%	10	-23.08%	5	-54.55%
31 Mar, 22	39	-18.75%	2,761,954	-13.96%	8109.08%	0.01%	13	-50.00%	11	22.22%
31 Dec, 21	48	17.07%	3,209,964	23.05%	9457.76%	0.02%	26	52.94%	9	28.57%
30 Sep, 21	41	-10.87%	2,608,658	17.04%	7740.82%	0.02%	17	-26.09%	7	-
30 Jun, 21	46	39.39%	2,228,924	37.70%	7084.95%	0.02%	23	-8.00%	7	600.00%
31 Mar, 21	33	266.67%	1,618,666	15.36%	5789.22%	0.01%	25	177.78%	1	-
31 Dec, 20	9	-	1,403,164	-	6354.91%	-	9	-	-	-

180 Life Sciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 18, 2023	Feldmann Marc	director	-	S-Sale	Sell	25,000	$0.19	$4.70K	115,497
Dec 18, 2023	Woody James N.	director, officer	Chief Executive Officer	P-Purchase	Buy	25,000	$0.19	$4.70K	66,888

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 18, 2023	Woody James N.	director, officer	Chief Executive Officer	P-Purchase	Buy	25,000	$0.19	$4.70K	66,888

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 18, 2023	Feldmann Marc	director	-	S-Sale	Sell	25,000	$0.19	$4.70K	115,497

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 12, 2024	Jordan Blair	director			Buy	-	-	-	-
Mar 11, 2024	JIMENEZ OMAR	director			Buy	-	-	-	-
Mar 11, 2024	Smith Ryan Lewis	director			Buy	-	-	-	-
Dec 28, 2023	Feldmann Marc	director	-	A-Award	Buy	135,377	-	-	250,874
Dec 18, 2023	Feldmann Marc	director	-	S-Sale	Sell	25,000	$0.19	$4.70K	115,497
Dec 18, 2023	Woody James N.	director, officer	Chief Executive Officer	P-Purchase	Buy	25,000	$0.19	$4.70K	66,888
Sep 08, 2023	Feldmann Marc	director	-	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 08, 2023	RAY RUSSELL T	director	-	A-Award	Buy	21,455	$1.36	$29.18K	24,409
Sep 08, 2023	RAY RUSSELL T	director	-	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 08, 2023	DeLuca Teresa	director	-	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 08, 2023	Woody James N.	director, officer	Chief Executive Officer	A-Award	Buy	75,000	$0.67	$50.25K	75,000
Sep 08, 2023	Francis Knuettel II	director	-	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 08, 2023	Rothbard Jonathan B.	officer	Chief Scientific Officer	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 06, 2023	STEINMAN LAWRENCE	director	-	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 06, 2023	Gold Lawrence Marshall	director	-	A-Award	Buy	21,455	-	-	24,745
Sep 06, 2023	Gold Lawrence Marshall	director	-	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 06, 2023	Pamir Ozan	officer	CFO	A-Award	Buy	15,000	$0.67	$10.05K	15,000
Sep 06, 2023	McGovern Jr. Donald A.	director	-	A-Award	Buy	25,186	-	-	55,285
Sep 06, 2023	McGovern Jr. Donald A.	director	-	A-Award	Buy	44,776	$0.67	$30.00K	44,776
Sep 06, 2023	McGovern Jr. Donald A.	director	-	A-Award	Buy	15,000	$0.67	$10.05K	15,000

The last insider sell of 180 Life Sciences's stock was made by Feldmann Marc on Dec 18 2023, selling 25,000 shares at $0.19 per share (valued at $4.70K). The last insider buy of ATNF was made by Woody James N. on Dec 18 2023, buying 25,000 shares at $0.19 per share (worth $4.70K).

180 Life Sciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	2	1	200.00%
Q3 2023	16	-	-
Q2 2023	7	-	-
Q4 2022	4	-	-
Q3 2022	4	-	-
Q2 2022	8	-	-
Q1 2022	4	-	-
Q4 2021	17	1	1700.00%
Q3 2021	10	4	250.00%
Q2 2021	3	-	-
Q1 2021	4	-	-
Q4 2020	8	21	38.10%
Q4 2019	-	3	-
Q3 2019	-	10	-
Q2 2019	-	5	-
Q1 2019	-	1	-
Q4 2017	-	-	-
Q2 2017	2	5	40.00%

2 total buy trades, and 1 total sell trades (buy/sell ratio of 2.00%) were made by 180 Life Sciences's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	1	1	100.00%
Q3 2023	-	-	-
Q2 2023	7	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	12	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	1	9	11.11%
Q4 2019	-	3	-
Q3 2019	-	9	-
Q2 2019	-	4	-
Q1 2019	-	-	-
Q4 2017	-	-	-
Q2 2017	2	1	200.00%

As of Q4 2023, Insider owners conducted 1 open market buy trades and 1 open market sell trades of 180 Life Sciences's stocks.

180 Life Sciences Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
CNSP	CNS Pharmaceuticals, Inc.
PHIO	Phio Pharmaceuticals Corp.
EFTR	eFFECTOR Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
CYTO	Altamira Therapeutics Ltd.
SONN	Sonnet BioTherapeutics Holdings, Inc.
ZURA	Zura Bio Limited
ENVB	Enveric Biosciences, Inc.
CDIO	Cardio Diagnostics Holdings, Inc.
PALI	Palisade Bio, Inc.

ATNF Ownership FAQ

Who Owns 180 Life Sciences?

180 Life Sciences is owned by institutional shareholders (15799.84%), insiders (2.78%), and public (-15702.62%). The largest institutional shareholder of 180 Life Sciences is RENAISSANCE TECHNOLOGIES LLC (5.86% of total shares) and the top mutual fund owner is SPECIAL OPPORTUNITIES FUND, INC. (0.06% of total shares).

Who are the major institutional shareholders of 180 Life Sciences?

180 Life Sciences's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, CUBIST SYSTEMATIC STRATEGIES, LLC, VANGUARD GROUP INC, and BLACKROCK INC.. The top five shareholders own together 9.85% of the company's share outstanding.

How many 180 Life Sciences shareholders are there?

As of Sep 2022, there are 27 institutional shareholders of 180 Life Sciences.

What percentage of 180 Life Sciences is owned by RENAISSANCE TECHNOLOGIES LLC?

RENAISSANCE TECHNOLOGIES LLC owns 114.74K shares of 180 Life Sciences, representing 5.86% of the company's total shares outstanding, valued at $207K (as of Mar 2023).

What percentage of 180 Life Sciences is owned by CITADEL ADVISORS LLC?

As of Mar 2023, CITADEL ADVISORS LLC holds 23.93K shares of 180 Life Sciences (ATNF), compromising 1.22% of the company, valued at $43.07M.

What percentage of 180 Life Sciences is owned by CUBIST SYSTEMATIC STRATEGIES, LLC?

CUBIST SYSTEMATIC STRATEGIES, LLC is the third largest holder of 180 Life Sciences. The company owns 23.52K of the company's shares outstanding (worth $42.34M).